Cargando…

18F-FDG PET/CT: an unexpected case of Huntington’s disease

BACKGROUND: Huntington’s disease (HD) is a rare, genetic neurodegenerative disorder often presenting with emotional, cognitive and behavioral abnormalities before manifestation of disease defining motor symptoms. Cognitive impairment is a frequent clinical feature caused by different dementia subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michels, Sebastian, Buchholz, Hans-Georg, Rosar, Florian, Heinrich, Isabel, Hoffmann, Manuela A., Schweiger, Susann, Tüscher, Oliver, Schreckenberger, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495557/ https://www.ncbi.nlm.nih.gov/pubmed/31043171 http://dx.doi.org/10.1186/s12883-019-1311-9

Ejemplares similares

Primary Staging of Prostate Cancer Patients with [(18)F]PSMA-1007 PET/CT Compared with [(68)Ga]Ga-PSMA-11 PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Dual-Time Point [(68)Ga]Ga-PSMA-11 PET/CT Hybrid Imaging for Staging and Restaging of Prostate Cancer
por: Hoffmann, Manuela A., et al.
Publicado: (2020)

Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination
por: Antwi, Kwadwo, et al.
Publicado: (2022)

Image quality analysis of (44)Sc on two preclinical PET scanners: a comparison to (68)Ga
por: Rosar, Florian, et al.
Publicado: (2020)

Detection Efficacy of (68)Ga-PSMA-11 PET/CT in Biochemical Recurrence of Prostate Cancer with Very Low PSA Levels: A 7-Year, Two-Center “Real-World” Experience
por: Burgard, Caroline, et al.
Publicado: (2023)

PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020)

Systemic Mastocytosis Treatment with Midostaurin: [(18)F]FDG PET/CT as a Potential Monitoring Tool for Therapy Outcome
por: Burgard, Caroline, et al.
Publicado: (2022)

Neuron-specific enolase has potential value as a biomarker for [(18)F]FDG/[(68)Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients
por: Rosar, Florian, et al.
Publicado: (2020)

Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2017)

Value of Combined PET Imaging with [(18)F]FDG and [(68)Ga]Ga-PSMA-11 in mCRPC Patients with Worsening Disease during [(177)Lu]Lu-PSMA-617 RLT
por: Khreish, Fadi, et al.
Publicado: (2021)

Early molecular imaging response assessment based on determination of total viable tumor burden in [(68)Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [(177)Lu]Lu-PSMA-617 radioligand therapy
por: Rosar, Florian, et al.
Publicado: (2021)

Construction and comparative evaluation of different activity detection methods in brain FDG-PET
por: Buchholz, Hans-Georg, et al.
Publicado: (2015)

The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
por: Hoffmann, Manuela A., et al.
Publicado: (2019)

Ventral and dorsal streams processing visual motion perception (FDG-PET study)
por: Becker-Bense, Sandra, et al.
Publicado: (2012)

Influence of [(18)F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
por: Werner, Sebastian, et al.
Publicado: (2023)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Histologically Confirmed Testicular Metastasis Revealed by [(89)Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging
por: Rosar, Florian, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

The Influence of Hypothyroid Metabolic Status on Blood Coagulation and the Acquired von Willebrand Syndrome
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2023)

Crossed cerebellar diaschisis on F-18 FDG PET/CT
por: Agrawal, Kanhaiya Lal, et al.
Publicado: (2011)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013)

Dialysis Related Amyloid Arthropathy on (18)FDG PET-CT
por: Kecler-Pietrzyk, A, et al.
Publicado: (2014)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

(18)F-FDG PET/CT in Pleural Epithelioid Hemangioendothelioma
por: Albano, Domenico, et al.
Publicado: (2017)

Hepatosplenic Candidiasis Detected by (18)F-FDG-PET/CT
por: Albano, Domenico, et al.
Publicado: (2016)

18F-FDG PET/CT in the diagnosis of Takayasu’s arteritis
por: Sargin, Gokhan, et al.
Publicado: (2018)

(18)FDG PET/CT in Pulmonary Carcinosarcoma and Brain Metastasis
por: Abbasain, Hamideh, et al.
Publicado: (2019)

Fasting Hypoglycemia on (18)F-FDG PET/CT Scan
por: Nakayama, Michihiro, et al.
Publicado: (2017)

(18)F-FDG PET/CT Findings in Cytomegalovirus Colitis
por: Kjaer, Anna Sophie L., et al.
Publicado: (2018)

Incidental “Urinoma” in (18)F-FDG PET/CT Scan
por: Gültekin, Aziz, et al.
Publicado: (2019)

F-18-FDG PET/CT findings of paraneoplastic dermatoses
por: Suga, Kazuyoshi
Publicado: (2022)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [(18)F] FDG-PET/CT
por: Gallo, Franklin, et al.
Publicado: (2019)

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k94scm33dnusqi8qbk5c39g1th